Resectable Lung Non-Small Cell Carcinoma clinical trials at UC Health
1 research study open to eligible people
“Studying the genes in a patient's tumor cells may help determine the best treatment for patients with certain genetic changes.”
open to eligible people ages 18 years and up
This phase III ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
at UC Davis UCSD UCSF